Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Ara h 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8618.60020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010FranceIgE6116.39020100923, Codrenau F
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE961.04020120528, Patelis A
1.3 - Rhinitis, Diagnosed2013BrazilIgE1011.90020130912, Lacerda Araujo LM
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE254.00020140821, Choi JS
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE21111.40020140331, Rockmann H
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.1.1 - Source Sensitized (SPT)2012SpainIgE796.33020121016, Javaloyes G
3.1.4 - Source Sensitized (SPT, IgE)2013NetherlandsIgE2213.64020130429, Aalberse JA
3.1.4 - Source Sensitized (SPT, IgE)2012SpainIgE687.40020120726, Pedrosa M
3.2.1 - Source Sensitized (IgE)2014FranceIgE6834.00020141107, Agabriel C
3.2.1 - Source Sensitized (IgE)2014GermanyIgE2759.26020140225, Lopes de Oliveira LC
3.2.1 - Source Sensitized (IgE)2013ItalyIgE240.00020131128, Calamelli E
3.2.1 - Source Sensitized (IgE)2013SloveniaIgE1612.50020131106, Homsak M
3.2.1 - Source Sensitized (IgE)2010SwedenIgE10029.00020100212, Asarnoj A
3.2.1 - Source Sensitized (IgE)2013ThailandIgE214.80020131011, Suratannon N
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1001.00020111214, Zheng YW
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE205.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE500.00020100212, Asarnoj A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE375.40520090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE214.76020090808, Krause S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011NetherlandsIgE80.00020110304, Vissers YM
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE3778.38020130428, Klemans RJ
5.2.1 - Source Exposed (Symptoms, SPT)2003FranceIgE5864.00020031107, Bernard H
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9912.12020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2014FranceIgE6860.00020141107, Agabriel C
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE3290.62020140225, Lopes de Oliveira LC
5.3.1 - Source Exposed (Symptoms, IgE)2013ItalyIgE2425.00020131128, Calamelli E
5.3.1 - Source Exposed (Symptoms, IgE)2014JapanIgE1681.25020140623, Nozawa A
5.3.1 - Source Exposed (Symptoms, IgE)2013SloveniaIgE1154.54020131106, Homsak M
5.3.1 - Source Exposed (Symptoms, IgE)2010SpainIgE5030.00020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2011SwedenIgE7454.05020110701, Moverare R
5.3.1 - Source Exposed (Symptoms, IgE)2010SwedenIgE3562.90020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2013ThailandIgE1926.30020131011, Suratannon N
5.3.1 - Source Exposed (Symptoms, IgE)2010United StatesIgE3080.00020101124, Vereda A
5.3.2 - Source Exposed (Symptoms, high IgE)2012TaiwanIgE2951.80020120319, Lin YT
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013NetherlandsIgE4358.14020130429, Aalberse JA
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011NetherlandsIgE12100.00020110304, Vissers YM
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004Netherlands / SwitzerlandIgE1764.70020041204, Mittag D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012SpainIgE5560.00020120726, Pedrosa M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004NetherlandsIgE (IB)3243.70020040416, Koppelman SJ
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceIgE3050.00020060630, Astier C
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1999GermanyIgE (IB)4065.0001999, Kleber-Janke T
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceSPT3040.00020060630, Astier C
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013ItalyBPT4812.50020131128, Calamelli E
5.7.2 - Source Exposed (Provocation Test - Ingestion)2010FranceIgE16675.30020100923, Codrenau F
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsIgE2050.00020070615, Flinterman AE
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013Sweden / USAIgE16740.50020130113, Lieberman JA
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsSPT944.40020070615, Flinterman AE
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
Developed by
Panservice